Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

P. L. Zinzani; E. Derenzini; C. Pellegrini; L. Rigacci; A. Fabbri; L. Gandolfi; L. Argnani; B. Casadei; A. Pulsoni; M. Gobbi; A. Perotti; A. Zaccaria; M. T. Voso; M. G. Cabras; A. De renzo

doi:10.1093/annonc/mdr633

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

P. L. Zinzani, E. Derenzini, C. Pellegrini, L. Rigacci, A. Fabbri, L. Gandolfi, L. Argnani, B. Casadei, A. Pulsoni, M. Gobbi, A. Perotti, A. Zaccaria, M. T. Voso, M. G. Cabras, A. De renzo

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	805-807
Number of pages	3
Journal	Annals of Oncology
Volume	23
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdr633
Publication status	Published - Mar 2012

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mdr633

Cite this

Zinzani, P. L., Derenzini, E., Pellegrini, C., Rigacci, L., Fabbri, A., Gandolfi, L., Argnani, L., Casadei, B., Pulsoni, A., Gobbi, M., Perotti, A., Zaccaria, A., Voso, M. T., Cabras, M. G., & De renzo, A. (2012). Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). Annals of Oncology, 23(3), 805-807. https://doi.org/10.1093/annonc/mdr633

Zinzani, PL, Derenzini, E, Pellegrini, C, Rigacci, L, Fabbri, A, Gandolfi, L, Argnani, L, Casadei, B, Pulsoni, A, Gobbi, M, Perotti, A, Zaccaria, A, Voso, MT, Cabras, MG & De renzo, A 2012, 'Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)', Annals of Oncology, vol. 23, no. 3, pp. 805-807. https://doi.org/10.1093/annonc/mdr633

@article{70d2172df0fe48018ec91698fb2644bf,

title = "Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)",

author = "Zinzani, {P. L.} and E. Derenzini and C. Pellegrini and L. Rigacci and A. Fabbri and L. Gandolfi and L. Argnani and B. Casadei and A. Pulsoni and M. Gobbi and A. Perotti and A. Zaccaria and Voso, {M. T.} and Cabras, {M. G.} and {De renzo}, A.",

year = "2012",

month = mar,

doi = "10.1093/annonc/mdr633",

language = "English",

volume = "23",

pages = "805--807",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "3",

}

TY - JOUR

T1 - Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

AU - Zinzani, P. L.

AU - Derenzini, E.

AU - Pellegrini, C.

AU - Rigacci, L.

AU - Fabbri, A.

AU - Gandolfi, L.

AU - Argnani, L.

AU - Casadei, B.

AU - Pulsoni, A.

AU - Gobbi, M.

AU - Perotti, A.

AU - Zaccaria, A.

AU - Voso, M. T.

AU - Cabras, M. G.

AU - De renzo, A.

PY - 2012/3

Y1 - 2012/3

UR - http://www.scopus.com/inward/record.url?scp=84857613613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857613613&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr633

DO - 10.1093/annonc/mdr633

M3 - Article

C2 - 22287683

AN - SCOPUS:84857613613

VL - 23

SP - 805

EP - 807

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this